The anti-inflammatory efficacy of melanocortin drugs is influenced by genetic variation at MC1R
Natalya Khodeneva, Camilla S A Davan-Wetton, Thomas E N Jonassen, Mauro Perretti, Trinidad Montero-Melendez · 2026
Read The anti-inflammatory efficacy of melanocortin drugs is influenced by genetic variation at MC1R by Natalya Khodeneva, Camilla S A Davan-Wetton, Thomas E N Jonassen, Mauro Perretti, Trinidad Montero-Melendez (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13507197.txt.
Description
Natalya Khodeneva and colleagues test, in 2026 work, whether inherited variants in the MC1R gene change how anti-inflammatory melanocortin drugs work. The gene also shapes hair and skin color, and red-hair variants weaken its function. Drugs targeting this receptor are in trials for arthritis, scleroderma, and bowel disease, yet gene effects on response were unknown.
Thirty variants were checked for signaling strength, and nine drugs were tested on blood from healthy volunteers. Loss of function formed a gradient, not a yes-or-no split, and each drug felt variants differently, from loss to gain of effect. Most drugs worked less well when variants were present. Gene screening should join future melanocortin drug trials.
Catalog record
| CREATOR | Natalya Khodeneva, Camilla S A Davan-Wetton, Thomas E N Jonassen, Mauro Perretti, Trinidad Montero-Melendez |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 54181 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |